Cite

HARVARD Citation

    Beers, C. et al. (n.d.). 100: The Role of FDG-PET in Staging and Treatment for Stage III NSCLC in Ontario between 2009-2017. Radiotherapy and oncology. pp. S44-. [Online]. 
  
Back to record